Publications
62
Citations
466
Est. group size
—
Recurring co-author estimate
Active years
60
Publishing since 1966
Robert Bell conducts research in medical pathology and molecular diagnostics, focusing on how genetic and molecular features of tumors relate to patient outcomes. Recent work examines blood cancers (myeloid neoplasms), soft-tissue and bone tumors, and nervous-system tumors, often using DNA/RNA sequencing and other molecular profiling techniques to identify markers that predict how a disease will progress.
Publication activity was low but steady through much of the decade and increased notably in 2024-2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through August 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
REU Site: Research Experiences for Undergraduates in Discrete and Applied Mathematics
1 earlier award
- NSF 1852066May 2019 – Apr 2023 · $262k awarded
REU Site: REU in Discrete and Applied Mathematics
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~9 · 5% small-team papers (≤3 authors) · across 18 venues
- Karyotypic clonal fraction predicts adverse outcome in TP53 -mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study
Journal of Clinical Pathology · 2025
- 95 Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Tumor and Epstein-Barr Virus-Associated Smooth Muscle Tumor Exhibit Distinct Methylation Profiles
Laboratory Investigation · 2025
- 1272 A 4-Gene Co-Alteration Signature (SIG4) Predictive of Favorable Outcomes in High-Grade TP53 Mutated Myeloid Neoplasms: An International TP53 Investigators Network (iTIN) Study
Laboratory Investigation · 2025
- 1295 Prognostic Impact of Chromosome 7 Losses in High-Grade TP53 Mutated Myeloid Neoplasms
Laboratory Investigation · 2025
- Single Cell Transcriptomic Analysis of Spinal Ependymoma from a Patient with NF2-related Schwannomatosis Indicates a Radial-Glia to Ependymal Cell Developmental Hierarchy
2025
- Somatic co‐alteration signatures are prognostic in high‐grade TP53 ‐mutated myeloid neoplasms
British Journal of Haematology · 2024
- Long‐Term Effects of Lecanemab on Biomarkers of Neurodegeneration in Plasma
Alzheimer s & Dementia · 2024
- Amyloid Plaque Reduction as a Surrogate Marker of Efficacy: Assessment of Amyloid PET and Change in CDR‐SB Utilizing Semi‐Mechanistic Model
Alzheimer s & Dementia · 2024
- Novel CRTC1::MRTFB(MKL2) Gene Fusion Detected in Myxoid Mesenchymal Neoplasms With Myogenic Differentiation Involving Bone and Soft Tissues
Modern Pathology · 2024
- EPCO-60. EXPRESSION OF EARLY PROGENITOR MARKERS WITHIN NF2-ASSOCIATED SPINAL EPENDYMOMA
Neuro-Oncology · 2024
- Spatial Transcriptomics of Spinal Ependymoma in NF2-related Schwannomatosis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma
JCO Precision Oncology · 2023
- Inappropriate use of clinical practices in Canada: a systematic review
Canadian Medical Association Journal · 2022
- 21. Co-existence of two activating variants in somatic overgrowth & vascular anomalies: 7 years' findings at a single center
Cancer Genetics · 2022
- Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
BMC Urology · 2021
- Laboratory Investigation×3
- Alzheimer s & Dementia×2
- Neuro-Oncology×2
- Canadian Medical Association Journal×1
- Genes & Cancer×1
- Swapna Joshi
Medicine · Indiana University
- Sean P. Ferris
Medicine · University of Michigan
- Tania Mamdouhi
Medicine · University of Michigan
- Ajay Patel
Medicine · Indiana University
- A. Villanueva Álvarez
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile